Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

• Christine A. Fargeas,
• Aurelio Lorico,
• Denis Corbeil

Affiliations

Christine A. Fargeas

Tissue Engineering Laboratories, Biotechnology Center (BIOTEC) and Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany

Aurelio Lorico

College of Medicine, Touro University Nevada, Henderson, NV, United States

Denis Corbeil

Tissue Engineering Laboratories, Biotechnology Center (BIOTEC) and Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany